Trademark Details For GILEAD THE TOWARD HEALTH EQUITY ONCOLOGY GRANT (Serial Number 97715079)

  •  Home
  •  Print
GILEAD THE TOWARD HEALTH EQUITY ONCOLOGY GRANT
0
0
0
0
Basic Information
Serial Number  United States - USPTO 97715079
Registration Number -
Mark
GILEAD THE TOWARD HEALTH EQUITY ONCOLOGY GRANT
Filing Date Dec-13-2022
Status
Pending  
SECOND EXTEN.. (731)
SECOND EXTENSION - GRANTED
Attorney Name

Cynthia Smuzynska

TTAB
0
Action Tags
  


  • Gilead Sciences, Inc.

  • Description Of Mark:
  • Color(s) Claimed:

036Insurance and financial

U.S Class(es): 100, 101, 102

Class Status: Active


05.03.25
24.01.02
26.17.01
26.17.04



Correspondences

NameCynthia Smuzynska GILEAD SCIENCES, INC.
Address333 LAKESIDE DRIVE FOSTER CITY, CA 94404 United States

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-16-2022NEW APPLICATION ENTERED   NWAPI
Jan-10-2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jan-11-2023NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Mar-27-2023ASSIGNED TO EXAMINER   DOCKD
Apr-04-2023EXAMINERS AMENDMENT -WRITTEN   CNEAR
Apr-04-2023EXAMINERS AMENDMENT E-MAILED   GNEAF
Apr-04-2023
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  
GNENO
Apr-04-2023EXAMINER'S AMENDMENT ENTERED   XAECI
Apr-04-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Apr-19-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
May-09-2023PUBLISHED FOR OPPOSITION   PUBOA
May-09-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jul-04-2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Dec-12-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Dec-12-2023SOU EXTENSION 1 FILED   EXT1S
Dec-12-2023SOU EXTENSION 1 GRANTED   EX1GS
Dec-14-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Jun-05-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Jun-05-2024SOU EXTENSION 2 FILED   EXT2S
Jun-05-2024SOU EXTENSION 2 GRANTED   EX2GS
Jun-13-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE